How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Serial Dilution Vials Market
- By Material Type: Glass, Plastic (Polypropylene), Polyethylene, Polycarbonate
- By Capacity: 1 mL, 2 mL, 5 mL, 10 mL, 15 mL
- By Closure Type: Screw Cap, Snap Cap, Crimp Cap, Flip Top Cap
- By Application: Pharmaceutical Research, Clinical Diagnostics, Food and Beverage Testing, Environmental Analysis, Biotechnology
- By Sterilization Method: Gamma Sterilized, Autoclaved, Ethylene Oxide Sterilized, Non-Sterile
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Glass leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Serial Dilution Vials Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 4
Capacity 5
Closure Type 4
Application 5
Sterilization Method 4
Companies profiled
Thermo Fisher Scientific
Merck KGaA (MilliporeSigma)
Sartorius AG
Eppendorf AG
Corning Incorporated
Greiner Bio-One International GmbH
DWK Life Sciences (Duran Group)
Nunc (part of Thermo Fisher Scientific)
Thomas Scientific
VWR International (part of Avantor)
Bio-Rad Laboratories
Sigma-Aldrich (part of Merck KGaA)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Eppendorf AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →DWK Life Sciences (Duran Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nunc (part of Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Thomas Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →VWR International (part of Avantor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bio-Rad Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sigma-Aldrich (part of Merck KGaA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BrandTech Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Analytical Scientific Instruments (ASI)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Labcon
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,166M by 2033 · 10.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Glass44.0
- Plastic (Polypropylene)18.0
- Polyethylene21.2
- Polycarbonate16.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$903.6M → $1,847M · 9.4%
Europe$629.8M → $1,304M · 9.5%
Asia Pacific$575.0M → $1,170M · 9.3%
Latin America$356.0M → $756.5M · 9.9%
Middle East and Africa$273.8M → $658.2M · 11.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.642026
10.642027
10.652028
10.662029
10.682030
10.682031
10.702032
10.712033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific23.0
- Merck KGaA (MilliporeSigma)22.4
- Sartorius AG5.2
- Eppendorf AG10.3
- Corning Incorporated6.3
- Greiner Bio-One International GmbH4.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type20.9%
Capacity17.1%
Closure Type25.3%
Application23.6%
Sterilization Method13.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe22.7
- Asia Pacific20.4
- Latin America13.2
- Middle East and Africa11.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 96 | 94 | 94 | 74 | 97 | 93 | 91 |
| Merck KGaA (MilliporeSigma) | 85 | 86 | 70 | 69 | 72 | 93 | 79 |
| Sartorius AG | 69 | 69 | 66 | 64 | 83 | 86 | 73 |
| Eppendorf AG | 64 | 72 | 79 | 75 | 71 | 81 | 74 |
| Corning Incorporated | 63 | 57 | 55 | 76 | 72 | 58 | 64 |
| Greiner Bio-One International GmbH | 48 | 71 | 68 | 53 | 56 | 52 | 58 |
| DWK Life Sciences (Duran Group) | 41 | 65 | 54 | 57 | 58 | 44 | 53 |
| Nunc (part of Thermo Fisher Scientific) | 36 | 59 | 54 | 51 | 37 | 58 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Merck KGaA (MilliporeSigma)
- Sartorius AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Merck KGaA (MilliporeSigma) | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Sartorius AG | ◐ | ✓ | ✓ | − | ✓ | ◐ |
| Eppendorf AG | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Corning Incorporated | ◐ | − | − | ◐ | ◐ | ◐ |
| Greiner Bio-One International GmbH | − | ✓ | ✓ | − | − | − |
| DWK Life Sciences (Duran Group) | − | ✓ | ◐ | ◐ | ◐ | − |
| Nunc (part of Thermo Fisher Scientific) | − | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific91
2Merck KGaA (MilliporeSigma)79
3Eppendorf AG74
4Sartorius AG73
5Corning Incorporated64
6Greiner Bio-One International GmbH58
7DWK Life Sciences (Duran Group)53
8Nunc (part of Thermo Fisher Scientific)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificMerck KGaA (MilliporeSigma)
Challenger2
Strong scale, closing on the leaders.
Sartorius AGEppendorf AG
Contender2
Focused players with pockets of strength.
Corning IncorporatedGreiner Bio-One International GmbH
Niche2
Specialists in a single segment or region.
DWK Life Sciences (Duran Group)Nunc (part of Thermo Fisher Scientific)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Serial Dilution Vials Market — a $466M beachhead inside a $7.25B market.
Beachhead (SOM)$466Mobtainable near-term
Serviceable (SAM)$2.71Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Glass
Best fit — highest urgency & budget in Material Type.
Economic buyer80 fit
Plastic (Polypropylene)
Strong fit — clear ROI and a fast path to value.
End user67 fit
Polyethylene
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Capacity & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Closure Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel25%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Serial Dilution Vials Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified21%
Evaluation13%
Closed-won7%
$15.4KCAC
$79KLTV
5.1:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Serial Dilution Vials Market is a high-growth opportunity — $7.46B by 2033, compounding at 11.3%.
TAM · 2025$3.17Btoday
TAM · 2033$7.46Bforecast
CAGR11.3%2027–2033
Cumulative$45.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.46BTotal addressable market
SAM$2.96BServiceable available market
SOM$496MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.3% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.46BLarge & growingTAM by 2033 at 11.3% CAGR
$2.96BServiceable nowreachable with today’s model
$496MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.82BBear7.3% CAGR
$7.46BBase11.3% CAGR
$9.55BBull14.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Capacity optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Serial Dilution Vials Market — a $1.28B market by 2033. Plan: grow share from 11.0% to 17.6%.
Market size · 2033$1.28Btotal addressable
Market CAGR5.7%2027–2033
Target share17.6%from 11.0% today
Revenue ambition$225Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.0% | 17.6% | At risk |
| Revenue | $134M | $225M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.4% | 41.1% | At risk |
| Customer retention | 85.0% | 95.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Capacity capability
A defensible second engine — invest in Capacity to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Capacity
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $32M capacity & capability investment
- Greenlight bolt-on M&A in Capacity
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Serial Dilution Vials Market conversation — a $6.43B market you can size, segment and defend in minutes.
Market size · 2033$6.43Btotal opportunity
Growth5.4%CAGR to 2033
Addressable buyers1,243+accounts in scope
Typical ROI7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7×return on cost, year one
< 4 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificMerck KGaA (MilliporeSigma)Sartorius AGEppendorf AGCorning IncorporatedGreiner Bio-One International GmbHDWK Life Sciences (Duran Group)Nunc (part of Thermo Fisher Scientific)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Serial Dilution Vials Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Serial Dilution Vials Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →SERD (Selective Estrogen Receptor Degrader) Drugs Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportSeratrodast Tablets Market
Market size, share, segmentation and regional forecast.
$509M market · 2025 base year
View reportSequencing Services Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSequencing Library Prep Kits Market
Market size, share, segmentation and regional forecast.
$842M market · 2025 base year
View reportSequencing Kit Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportSequencing Gene Analyzer Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportSeptum-Type Infusion Connector Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportSeptum Cap Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportSeptoplasty Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSeptin 9 Methylated Colorectal Cancer Detection Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportSeptic Shock Therapy Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportSeptic Shock Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.